SIM
GILD icon

Sentry Investment Management’s Gilead Sciences GILD Stock Holding History

Sentry Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,124
Closed -$383K – 201
2025
Q4 		$383K Hold
3,124
– – 0.25% 77
2025
Q3 		$369K Sell
3,124
-881
-22% -$100K 0.25% 77
2025
Q2 		$445K Hold
4,005
– – 0.25% 82
2025
Q1 		$423K Sell
4,005
-1,196
-23% -$123K 0.29% 68
2024
Q4 		$480K Sell
5,201
-847
-14% -$76.3K 0.23% 95
2024
Q3 		$507K Hold
6,048
– – 0.21% 107
2024
Q2 		$415K Sell
6,048
-1,239
-17% -$82.7K 0.18% 127
2024
Q1 		$534K Buy
7,287
+754
+12% +$58K 0.21% 118
2023
Q4 		$529K Sell
6,533
-702
-10% -$54.6K 0.23% 105
2023
Q3 		$542K Sell
7,235
-1,560
-18% -$120K 0.26% 81
2023
Q2 		$678K Buy
8,795
+519
+6% +$41.4K 0.26% 97
2023
Q1 		$687K Sell
8,276
-369
-4% -$30.6K 0.28% 89
2022
Q4 		$742K Buy
8,645
+281
+3% +$22.3K 0.33% 68
2022
Q3 		$516K Hold
8,364
– – 0.24% 86
2022
Q2 		$517K Sell
8,364
-1,629
-16% -$101K 0.23% 92
2022
Q1 		$594K Sell
9,993
-2,417
-19% -$155K 0.19% 116
2021
Q4 		$901K Hold
12,410
– – 0.24% 106
2021
Q3 		$867K Sell
12,410
-1,813
-13% -$127K 0.25% 96
2021
Q2 		$979K Sell
14,223
-11,937
-46% -$797K 0.25% 101
2021
Q1 		$1.69M Sell
26,160
-44,150
-63% -$2.85M 0.47% 43
2020
Q4 		$4.1M Sell
70,310
-56,210
-44% -$3.39M 0.21% 124
2020
Q3 		$8M Sell
126,520
-22
-0% -$1.53K 0.44% 55
2020
Q2 		$9.74M Buy
126,542
+2,508
+2% +$192K 0.59% 34
2020
Q1 		$9.27M Buy
124,034
+44,887
+57% +$3.1M 0.68% 33
2019
Q4 		$5.14M Hold
79,147
– – 0.31% 85
2019
Q3 		$5.02M Hold
79,147
– – 0.33% 81
2019
Q2 		$5.35M Hold
79,147
– – 0.35% 69
2019
Q1 		$5.14M Sell
79,147
-49,225
-38% -$3.27M 0.36% 61
2018
Q4 		$8.03M Sell
128,372
-3,325
-3% -$232K 0.58% 41
2018
Q3 		$10.2M Buy
131,697
+6,365
+5% +$481K 0.62% 33
2018
Q2 		$8.88M Sell
125,332
-11,857
-9% -$837K 0.58% 38
2018
Q1 		$10.3M Sell
137,189
-13,028
-9% -$1.04M 0.63% 35
2017
Q4 		$10.8M Buy
150,217
+8,631
+6% +$655K 0.59% 40
2017
Q3 		$11.5M Buy
141,586
+1,486
+1% +$114K 0.43% 41
2017
Q2 		$9.92M Buy
140,100
+1,606
+1% +$107K 0.39% 43
2017
Q1 		$9.41M Sell
138,494
-595
-0.4% -$41.8K 0.38% 43
2016
Q4 		$9.96M Sell
139,089
-55
-0% -$4.09K 0.42% 42
2016
Q3 		$11M Buy
139,144
+11,707
+9% +$951K 0.48% 40
2016
Q2 		$10.6M Buy
127,437
+1,123
+0.9% +$99.7K 0.47% 39
2016
Q1 		$11.6M Sell
126,314
-4,319
-3% -$389K 0.52% 34
2015
Q4 		$13.2M Sell
130,633
-27,039
-17% -$2.81M 0.61% 26
2015
Q3 		$15.5M Buy
157,672
+12,718
+9% +$1.41M 0.76% 23
2015
Q2 		$17M Buy
144,954
+11,493
+9% +$1.26M 0.8% 20
2015
Q1 		$13.1M Buy
133,461
+21,286
+19% +$2.16M 0.62% 27
2014
Q4 		$10.6M Buy
112,175
+14,702
+15% +$1.52M 0.51% 32
2014
Q3 		$10.4M Sell
97,473
-5,228
-5% -$512K 0.53% 30
2014
Q2 		$8.52M Buy
102,701
+12,714
+14% +$990K 0.44% 36
2014
Q1 		$6.38M Hold
89,987
– – 0.34% 45
2013
Q4 		$6.76M Buy
89,987
+46,402
+106% +$3.23M 0.36% 45
2013
Q3 		$2.74M Buy
43,585
+20,291
+87% +$1.21M 0.16% 98
2013
Q2 		$1.19M Buy
+23,294
New +$1.21M 0.07% 142

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sentry Investment Management's GILD Position: Q1 2026 in Review

Sentry Investment Management sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 3,124 shares — an estimated $383K sold.

Sentry Investment Management first reported a position in GILD in Q2 2013 and held it in 51 quarters. The position peaked at $17M in Q2 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Sentry Investment Management reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • Sentry Investment Management sold 3,124 Gilead Sciences shares in Q1 2026, an estimated $383K.
  • Sentry Investment Management first reported a position in Gilead Sciences in Q2 2013 and held it in 51 quarters.
  • Sentry Investment Management's Gilead Sciences position peaked at $17M in Q2 2015.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Sentry Investment Management's 13F filing for Q1 2026, filed 8 May 2026.